Discovery Laboratories Inc. (NASDAQ:WINT) was down 9.2% on Monday . The stock traded as low as $2.60 and last traded at $2.65, with a volume of 149,553 shares. The stock had previously closed at $2.92.

Several equities research analysts recently weighed in on WINT shares. Zacks Investment Research downgraded shares of Discovery Laboratories from a “buy” rating to a “hold” rating in a research note on Thursday, July 21st. HC Wainwright reaffirmed a “buy” rating on shares of Discovery Laboratories in a research note on Friday, May 20th.

The firm’s market cap is $21.56 million. The firm has a 50 day moving average of $2.05 and a 200 day moving average of $2.20.

Discovery Laboratories (NASDAQ:WINT) last announced its quarterly earnings results on Wednesday, August 10th. The company reported ($1.29) earnings per share for the quarter, beating analysts’ consensus estimates of ($1.64) by $0.35. On average, analysts predict that Discovery Laboratories Inc. will post ($5.87) earnings per share for the current year.

Windtree Therapeutics, Inc, formerly Discovery Laboratories, Inc, is a biotechnology company. The Company is focused on developing KL4 surfactant therapies for respiratory diseases and other potential applications. The Company operates through the research and development of products focused on surfactant therapies for respiratory disorders and diseases, and the manufacture and commercial sales of approved products segment.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.